Cargando…

Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty

OBJECTIVE: Longitudinal data regarding random luteinizing hormone (LH) concentrations in patients with idiopathic central precocious puberty (ICPP) during treatment are limited. Therefore, we sought to evaluate random LH and estradiol concentrations during monthly leuprolide injection and their asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiromrat, Pattara, Panamonta, Ouyporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745452/ https://www.ncbi.nlm.nih.gov/pubmed/30592192 http://dx.doi.org/10.4274/jcrpe.galenos.2018.2018.0213

Ejemplares similares

SUN-LB70 Bone Mineral Density, Vitamin D Status and Bone Turnover Markers in Thai Youth With Graves’ Disease: A Pilot Study
por: Wiromrat, Pattara, et al.
Publicado: (2020)

The age of onset of pubertal development in healthy Thai girls in Khon Kaen, Thailand
por: Jirawutthinan, Nongnapat, et al.
Publicado: (2013)

Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
por: Neely, E. Kirk, et al.
Publicado: (2010)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
por: Vurallı, Doğuş, et al.
Publicado: (2020)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
por: Schubert, Stefanie, et al.
Publicado: (2021)

The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis
por: Wang, Lan, et al.
Publicado: (2021)

Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty
por: Omar, Anjumanara Anver, et al.
Publicado: (2020)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?
por: Lee, Dong Seong, et al.
Publicado: (2013)

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty
por: Eugster, Erica A, et al.
Publicado: (2021)

The effect of overweight on the luteinizing hormone level after gonadorelin stimulation test in girls with idiopathic central precocious puberty
por: Lee, Hyun Young, et al.
Publicado: (2018)

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study
por: Valenzise, M., et al.
Publicado: (2023)

Changes in pubertal hormones, neurotransmitters and sleep patterns during sleep in girls with precocious puberty
por: Betul, Ersoy, et al.
Publicado: (2013)

Altered Brain Structure and Functional Connectivity Associated with Pubertal Hormones in Girls with Precocious Puberty
por: Chen, Tao, et al.
Publicado: (2019)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for diagnosis of precocious puberty in Korean girls?
por: Lee, Sun Hee, et al.
Publicado: (2013)

Psychosocial Aspects in Girls with Idiopathic Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2012)

Precocious puberty in girls
por: Chittwar, Sachin, et al.
Publicado: (2012)

Idiopathic central precocious puberty in girls: presentation factors
por: Prété, Géraldine, et al.
Publicado: (2008)

Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty
por: Lee, Hae Sang, et al.
Publicado: (2016)

Clinical risk score for central precocious puberty among girls with precocious pubertal development: a cross sectional study
por: You, Jingyu, et al.
Publicado: (2021)

The utilization of basal luteinizing hormone in combination with the basal luteinizing hormone and follicle-stimulating hormone ratio as a diagnostic tool for central precocious puberty in girls
por: Chotipakornkul, Nuntika, et al.
Publicado: (2023)

Visceral fat thickness and its associations with pubertal and metabolic parameters among girls with precocious puberty
por: Kim, Dong Wook, et al.
Publicado: (2018)

Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study
por: Klein, Karen O, et al.
Publicado: (2023)

The Association of Gut Microbiota With Idiopathic Central Precocious Puberty in Girls
por: Dong, Guoqing, et al.
Publicado: (2020)

The Role of SNPs in the Pathogenesis of Idiopathic Central Precocious Puberty in Girls
por: Toutoudaki, Konstantina, et al.
Publicado: (2023)

Adequacy of basal luteinizing hormone levels in the diagnosis of central precocious puberty
por: Vurallı, Doğuş, et al.
Publicado: (2020)

Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty
por: Kim, You Jin, et al.
Publicado: (2013)

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2020)

Idiopathic central precocious puberty with Prader–Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog
por: Kobayashi, Mami, et al.
Publicado: (2022)

Urinary Bisphenol A Levels in Girls with Idiopathic Central Precocious Puberty
por: Durmaz, Erdem, et al.
Publicado: (2014)

Risk factors for idiopathic central precocious puberty of girls in Fujian province
por: Chen, Ruimin, et al.
Publicado: (2015)

Serum Nesfatin-1 Levels in Girls with Idiopathic Central Precocious Puberty
por: Altıncık, Ayça, et al.
Publicado: (2018)

The Assessment of Brain Volume Differences in Idiopathic Central Precocious Puberty Girls; Comparison of Age-Matched Girls and Normal Puberty Girls
por: Park, Shin-Eui, et al.
Publicado: (2021)

Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment
por: Yüce, Özge, et al.
Publicado: (2020)

THU195 6-Month Subcutaneous Leuprolide Acetate Achieved And Maintained Hormonal And Clinical Suppression In All Weight Groups Of Children With Central Precocious Puberty
por: Miller, Bradley S, et al.
Publicado: (2023)

The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls
por: Cao, Ruixue, et al.
Publicado: (2021)

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
por: Lee, Peter A, et al.
Publicado: (2011)

Positive effect of combined exercise on adipokines levels and pubertal signs in overweight and obese girls with central precocious puberty
por: Shokri, Elnaz, et al.
Publicado: (2021)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty
por: Wojniusz, Slawomir, et al.
Publicado: (2016)

Test on kisspeptin levels in girls with idiopathic central precocious puberty and its significance
por: Yang, Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ea52i0b85cdtrmim9plnq0kj11